Islet cell autoantigen of 69 kDa (ICA69) is a cytosolic protein of still unknown function. Involvement of ICA69 in neurosecretion has been suggested by the impairment of acetylcholine release at neuromuscular junctions upon mutation of its homologue gene ric-19 in C. elegans. In this study, we have further investigated the localization of ICA69 in neurons and insulinoma INS-1 cells. ICA69 was enriched in the perinuclear region, whereas it did not co-localize with markers of synaptic vesicles/synaptic-like microvesicles. Confocal microscopy and subcellular fractionation in INS-1 cells showed co-localization of ICA69 with markers of the Golgi complex and, to a minor extent, with immature insulin-containing secretory granules. The association of ICA69 with these organelles was confirmed by immunoelectron microscopy. Virtually no ICA69 immunogold labeling was observed on secretory granules near the plasma membrane, suggesting that ICA69 dissociates from secretory granule membranes during their maturation. In silico sequence and structural analyses revealed that the N-terminal region of ICA69 is similar to the region of arfaptins that interacts with ARF1, a small GTPase involved in vesicle budding at the Golgi complex and immature secretory granules. ICA69 is therefore a novel arfaptin-related protein that is likely to play a role in membrane trafficking at the Golgi complex and immature secretory granules in neurosecretory cells.
Originally identified by immunoscreening of an islet cDNA expression library with prediabetic sera, islet cell autoantigen of 69 kDa (ICA69) 1 is an evolutionary conserved gene with homologues in the nonmammalian model organisms Drosophila melanogaster and Caenorhabditis elegans (1) (2) (3) . Like most antigens of type 1 diabetes, ICA69 is enriched in pancreatic ␤-cells and neurons (4) . Use of alternative exons in the 5Ј-untranslated region of the ICA69 gene can affect its tissue expression (5) . Although ICA69 deficiency in mice does not induce any obvious phenotype, the knockout of its C. elegans homologue compromises neurotransmission (3, 6) . This finding has led to the hypothesis that ICA69, despite lacking membrane anchoring signals, is linked to neuronal synaptic vesicles (SVs) and the related synaptic-like microvesicles (SLMVs) of endocrine cells (3) . We now show that ICA69 is mostly associated with the Golgi complex and, to a less extent, with immature secretory granules (ISGs) of insulinoma cells. ICA69 is similar to arfaptins, which act as effectors of the small GTPases ARF and Rac (7, 8) . Thus, ICA69 is likely to play a role in vesicular transport regulated by small GTP-binding proteins at the Golgi complex and ISGs in ␤-cells and secretory cells in general.
EXPERIMENTAL PROCEDURES
Materials-The following antibodies were used: affinity-purified rabbit antibodies against residues 471-483 of human ICA69 (pICA69) (1) and against ICA512 ectodomain (9) ; mouse monoclonal antibodies against human ICA69 (mICA69); GAD65 (9) ; ␤ЈCOP (Drs. J. Fuellekrug and K. Simons, Max Planck Institute for Molecular Cell Biology and Genetics, Dresden, Germany); the 18-kDa fragment of secretogranin II (Dr. S. Tooze, Cancer UK, London, UK) (10, 11); giantin (Dr. H.-P. Hauri, Biozentrum, Basel, Switzerland) (12); TGN38, GM130, syntaxin 6, and carboxypeptidase E/H (BD Transduction Laboratories, Heidelberg, Germany); ARF1 (Affinity Bioreagents, Golden, CO); proinsulin (nonreactive against insulin) (Research Diagnostics); synaptophysin (Synaptic Systems, Goettingen, Germany); transferrin receptor (Zymed Laboratories, South San Francisco, CA); insulin and ␥-tubulin (Sigma), goat anti-rabbit and anti-mouse IgGs conjugated to Alexa 488 or Alexa 568 (Molecular Probes, Inc., Eugene, OR); and goat anti-rabbit and goat anti-mouse IgGs conjugated with gold particles (Electron Microscopy Sciences, Fort Washington, PA). All other reagents were from Sigma, unless otherwise specified.
Immunofluorescence-Mouse brains were fixed and immunolabeled as described (13) . Rat INS-1 cells, hamster HIT-15, and mouse MIN6 insulinoma cells were cultured and processed as described (13) (14) (15) (16) . For ␥-tubulin staining, cells were fixed with cold methanol (Ϫ20°C) for 5 min and labeled as described (17) . Antibodies were diluted as follows: pICA69 (1:200) and mICA69 (1:20) . All other antibodies were used according to the providers' instructions. Confocal microscopy was performed with an LSM 510 station (Carl Zeiss, Jena, Germany). For drug treatments, cells were incubated for 1 h or 30 min in normal medium plus 20 g/ml nocodazole or 2 g/ml BFA, respectively. For mild destabilization of the microtubule cytoskeleton, cells were processed as described (18) .
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supernatant was collected while the high speed pellet was brought back to the original volume with homogenization buffer. Protein concentrations were measured with the BCA reagent (Pierce). For Western blotting, proteins were separated by 10% SDS-PAGE and blotted with the following antibodies: pICA69 (1:1,000), mICA69 (1:200), and synaptophysin (1:10,000). Immunoreactivity was detected by chemiluminescence (Amersham Biosciences) using a LAS-1000 Bioimaging System (Fujifilm, Tokyo, Japan). Immunoprecipitation was carried out essentially as described (21) . 600 l of the extracts were incubated overnight at 4°C with 10 l of mICA69, 25 l of pICA69, or 10 l of rabbit IgGs as a negative control.
In Immunoelectron Microscopy-Immunoelectron Microscopy on gradient fractions was performed as described (27) using antibodies pICA69 (1:50) and anti-TGN38 (1:25) followed by goat anti-rabbit and anti-mouse antibodies conjugated with 10-and 6-nm gold particles, respectively. Immunoelectron microscopy on ultrathin cryostat sections was performed as described (28) with minor variations. INS-1 cells were fixed with 4% paraformaldehyde and 0.05% glutaraldehyde in phosphate-buffered saline. Sections were simultaneously labeled with pICA69 (1:10) and anti-giantin (1:10) or anti-insulin (1:100) antibodies, followed by 6-and 12-nm gold-conjugated anti-mouse and anti-rabbit antibodies, respectively. As controls, primary antibodies were omitted.
Data Base Searches and Structural Predictions-Data base searches were carried out with the programs BLASTP and PSI-BLAST (29) using standard parameters against the nonredundant NCBI protein data base (release of November 27, 2001 ). Multiple sequence alignments were produced with the program ClustalX (30, 31) , where most synaptic terminals of the cerebellar cortex are found. E and F, high power magnifications showing that ICA69 is associated with perinuclear structures (arrowheads), whereas it does not co-localize with GAD65 (E) or synaptophysin (F) in synaptic terminals around the cell bodies (arrows) and axon hillocks (asterisks) of Purkinje cells.
fined. Structure prediction was done using the programs 3D-PSSM (32) and PredictProtein (33) .
RESULTS

Characterization of Two Antibodies Directed against Distinct
Epitopes of ICA69 -The localization of ICA69 in neurons and insulinoma cells was investigated by employing two distinct antibodies directed against ICA69. The first antibody consists of affinity-purified rabbit IgGs (polyclonal ICA69, or pICA69), which were raised against residues 471-483 at the C-terminal end of ICA69 (1). The second antibody was a monoclonal IgG (mICA69), which was obtained by mouse immunization with full-length recombinant ICA69 expressed in bacteria as a fusion protein with glutathione S-transferase. To map the epitope recognized by mICA69, the N-terminal (amino acids 1-239) and C-terminal (amino acids 230 -483) halves of ICA69 were independently expressed as 35 S-labeled polypeptides by in vitro transcription/translation and incubated either with mICA69 or control mouse IgG for immunoprecipitation followed by SDS-PAGE and autoradiography (Fig. 1A) . This analysis shows that mICA69 selectively immunoprecipitated the N-terminal ICA69 polypeptide, whereas control mouse IgG did not react with either ICA69 fragment. Whereas the N-terminal fragment of ICA69 has a molecular mass of 28 kDa, it migrated as a 35-kDa protein by SDS-PAGE. The aberrant electrophoretic mobility of the N-terminal domain may account for the overall slower migration of native ICA69, which has a molecular mass of 54.6 kDa but migrates as a 60-kDa protein under the present conditions for SDS-PAGE (1) (Fig. 1B) . By Western blotting on PNS from rat brain (Fig. 1B) and INS-1 cells (Fig.  1C) , both mICA69 and pICA69 antibodies recognized indeed a protein doublet of 60 kDa (R f ϭ 0.34 and 0.37, respectively). Given its detection with two antibodies directed against distinct ICA69 epitopes, this 60-kDa protein doublet is likely to represent ICA69. The amino acid sequence of ICA69 contains a second methionine at position 26. Initiation of translation at this alternative methionine may explain the presence of a protein doublet upon in vitro translation (Fig. 1A) and in cell extracts (Fig. 1, B and C) . Moreover, mICA69 and pICA69
FIG. 3. Confocal microscopy for ICA69 (pseudored), markers of the Golgi complex and SGs in rat insulinoma INS-1 cells (pseudogreen).
ICA69 overlaps significantly with TGN38 (A) and giantin (B). Partial overlap was also found with ␤ЈCOP (C), with which the co-localization extended to structures outside the Golgi region, and with GM130 (D). Double labelings for ICA69 and proinsulin showed some co-distribution in the perinuclear region (E). F, ICA69 codistributed with insulin in the perinuclear area (arrowhead) but not near the plasma membrane, where MSGs accumulate (long arrow). antibodies immunoprecipitated the same 60-kDa protein doublet from INS-1 cell extracts (Fig. 1D) and produced an identical particulate staining by immunocytochemistry ( Fig. 2A) . Partitioning of ICA69 between cytosolic and particulate fractions (Fig. 1C) suggested that a pool of the protein is membrane-associated, despite lacking membrane targeting motifs. Fig. 2A) , whereas virtually no signal was found at the tip of neurite-like extensions where synaptophysin and SLMVs are concentrated (Fig.  2B) (34, 35) . ICA69 distribution was also different from that of ICA512, a protein enriched in mature secretory granules (MSGs) near the plasma membrane (Fig. 2C) (9) . Double immunofluorescence on mouse cerebellar sections showed that ICA69 is found in the perinuclear region of Purkinje cells (Fig.  2, D-F) . This pattern did not resemble that of GAD65, which is associated with SVs of GABA-ergic synapses around Purkinje cells and throughout the cerebellar cortex (Fig. 2, D and E) (24, 36) . There was also no co-localization of ICA69 with synaptophysin (Fig. 2F) , a general marker of SVs and synaptic terminals (34) . Similar observations were made upon subcellular fractionation of rat brain synaptosomes. As expected (37), synaptophysin was concentrated in the LP2 fraction (crude SVs) and further enriched in the sucrose-gradient vesicle fraction (purified SVs), whereas ICA69 was most abundant in the LP1 (large membranes and cytoskeleton) and LS2 (synaptosol) fractions (not shown). These data indicated that ICA69 is neither enriched on neuronal SVs nor on SLMVs and MSGs of insulinoma cells.
ICA69 Is Not Enriched in Neuronal Synaptic Vesicles and Synaptic-like-Microvesicles of INS-1 Cells-Previous
Localization of ICA69 to the Golgi Complex and Immature Secretory Granules by Confocal Microscopy-We compared the perinuclear pattern of ICA69 with that of proteins enriched in the Golgi compartment of INS-1 cells (Fig. 3, A-F) . ICA69 was co-localized in part with TGN38 (Fig. 3A) and giantin (Fig. 3B) . Giantin is a general marker of the Golgi complex (12), whereas TGN38 is enriched at the trans-Golgi network (TGN) (38, 39) . ICA69 also partially overlapped with the peripherally associated Golgi proteins ␤ЈCOP (Fig. 3C) (40 -43) and GM130 (Fig.  3D) (44) . Finally, ICA69 overlapped in part with proinsulin, which is found in ISGs, but not in MSGs (Fig. 3E) (45, 46) . It also co-distributed with insulin in the Golgi region but not near the plasma membrane (Fig. 3F) . The significant, albeit partial, colocalization of ICA69 with Golgi markers GM-130 and TGN38 was confirmed in hamster insulinoma HIT-cells and mouse insulinoma MIN-6 cells (Fig. 4, A-I) . These results suggested that ICA69 is broadly associated with the Golgi complex and, to a much lesser extent, with ISGs.
Localization of ICA69 at the Golgi Complex and Immature Secretory Granules by Immunoelectron Microscopy-By immunoelectron microscopy on cryoultrathin sections of INS-1 cells, ICA69 was found on Golgi stacks close to giantin (Fig. 5A) and at budding sites of vesicles from the Golgi complex (Fig. 5B) and SGs (Fig. 5C ). Overall, ICA69 was found on a minority of SGs (Fig. 5E) , as identified by double gold immunolabeling with insulin (not shown). ICA69-positive SGs were most abundant in the central region of the cell (Fig. 5D) , with a mean distance from the plasma membrane that was about twice the mean distance of ICA69-negative SGs and SGs in general (Fig.  5F ). These data indicated that ICA69 is associated with the Golgi complex, whereas a minor pool is also found on ISGs, which are significantly more distant from the plasma membrane than the total of the SGs.
Enrichment of ICA69 on the Golgi Complex by Subcellular
Fractionation-Fractionation of INS-1 cell extracts on sucrose density gradients separated two main peaks of ICA69 at 0.9 and 1.1 M sucrose (Fig. 6A) . These fractions included the peaks of the TGN proteins TGN38 and syntaxin 6 (0.9 M sucrose) and the early Golgi marker GM130 (1.1 M sucrose) (Fig. 6B, left  panel) . The soluble pools of ICA69 and GM130 were recovered in light fractions (0.4 -0.5 M sucrose), whereas low levels of ICA69 were detected in 1.2-1.4 M sucrose fractions. These last fractions contained the first peak of the SG marker CPE (Fig.  6B, middle panel) , indicating the presence of ISGs, which are lower in density than the MSGs. A second pool of CPE was found in denser fractions (1.5-1.7 M sucrose) together with p18, a marker of MSGs (11, 47) . The peaks of ICA69 were slightly shifted from those of synaptophysin and transferrin receptor, which overlapped in 1.0 M sucrose fractions (Fig. 6B, right  panel) (48) . The gradient fractions were also examined by immunoelectron microscopy. The 0.9 M sucrose fraction contained In double labelings, the staining with the pICA69 antibody (12-nm gold) was compared with the staining for giantin (6-nm gold). ICA69 colocalizes with giantin on Golgi cisternae (A). In addition, it is found on SGs (A), which sometimes seem to be budding from the Golgi (B). C, ICA69 is also present on vesicles which appear to emerge from SGs. D, ICA69-negative SGs concentrate near the plasma membrane of INS-1 cells, whereas ICA69-positive SGs are preferentially found toward the cell center. E, ICA69 was detected on 27 (15.7%) of 172 SGs counted in 10 INS-1 cells. F, the mean distance of the ICA69-positive SGs from the plasma membrane (840 nm, S.E. ϭ 99 nm) was about twice the mean distance of the ICA69-negative SGs (415 nm, S.E. ϭ 37 nm; p ϭ 0.000022) and of the overall mean distance of all measured SGs from the plasma membrane (482 nm, S.E. ϭ 37 nm, p ϭ 0.00057). The bar in D represents 150 nm for A and B, 100 nm for C, and 250 nm for D.
membranous, ribbon-like structures that resemble Golgi stacks and were positive for ICA69 and TGN38 (Fig. 6C, left panel) , whereas the 1.35 M sucrose fraction contained SGs positive for ICA69 (Fig. 6C, right panel) . These data confirmed the association of ICA69 with Golgi membranes and, to a lesser extent, with ISGs.
The Distribution of ICA69 Is Nocodazole-and BFA-sensitive-We analyzed whether drugs that affect the organization of the Golgi complex alter the distribution of ICA69 in INS-1 cells. Nocodazole treatment caused a major loss of ICA69 immunoreactivity in the perinuclear region (Fig. 7A) . Some ICA69, however, could still be detected on TGN38-labeled Golgi fragments scattered throughout the cells. Treatment of cells with nocodazole followed by taxol causes a redistribution and mild destabilization of the microtubule cytoskeleton similar to what occurs in the prophase of mitosis (18, 49) . In these conditions, ICA69 had a bipolar distribution that overlapped with TGN38 at opposite sides of the nucleus (Fig. 7B) , near the centrioles (Fig. 7C) . BFA causes the release of coatomers from Golgi membranes and the retrieval of resident Golgi enzymes into the endoplasmic reticulum by inhibiting guanine nucleotide exchange on ARF (50) . It also leads to the formation of a hybrid TGN-endosomal system near the microtubule-organizing center (MTOC) by inhibiting the TGN-endosome recycling pathway (51) (52) (53) (54) . ICA69 immunoreactivity was significantly reduced upon BFA treatment (compare Fig. 7, D-F, with Figs.  2, 3, and 7 , B and C), suggesting a redistribution of ICA69 in the cytosol, similar to what has been shown for ␤ЈCOP (55) . A pool of ICA69, however, retained a juxtanuclear position within one or two brightly stained clusters that were distinct from GM130-positive Golgi remnants (Fig. 7E) (44, 56) but that still contained some TGN38 (Fig. 7D ) and especially syntaxin 6 (Fig. 7F) . Syntaxin 6 participates in the TGN-endosomal recycling pathway and is also found on ISGs (11, 57) . These observations implied that the perinuclear concentration of ICA69 is microtubule-dependent and emphasized the relationship of ICA69 with the Golgi complex.
ICA69 Is Related to Arfaptin-Iterated BLAST searches with the ICA69 sequence against current protein data bases indicated that the N-terminal region of ICA69 is significantly sim- ilar to arfaptins (Fig. 8A) , with an expect value of 2e-70 at convergence of PSI-BLAST searching. Back PSI-BLAST searches with human arfaptin 1 identified the ICA69 family with an expect value of 9e-73 at the third iteration. Arfaptin 1 and 2 are cytosolic proteins that bind small GTPases of the ARF family (8) and Rac1 (7). Arfaptin 1, in particular, is recruited to Golgi membranes by ARF1-GTP and acts as negative regulator of ARF1 function (8, 58, 59) . Arfaptin is composed of three ␣-helices that dimerize to form the binding interface for small GTPases. Both dimer subunits contribute to a domain that is structurally related to the Dbl homology domain of Tiam, a guanine nucleotide exchange factor for Rac (60 -62) . The secondary structure of ICA69 N-terminal half is predicted to be primarily ␣-helical (Fig. 8A) and coincides with that of human arfaptin 2, as deduced from its tertiary structure (63) . Thus, it is likely that ICA69 folds like arfaptins and that ICA69 dimerization generates a Dbl homology-like domain that binds small GTPases. Through this interaction, ICA69 may participate in regulating membrane trafficking at the Golgi complex and ISGs. These functional implications were sustained by the finding that both mICA69 and pICA69 antibodies co-immunoprecipitated a yet unidentified small GTP-binding protein from INS-1 cell extracts (Fig. 8B) . This small GTP-binding protein comigrated with ARF1 (Fig. 7B ) but did not react with the anti-ARF1 antibody following immunoblotting of the material immunoprecipitated by the ICA69 antibodies (not shown). Interestingly, several of the residues involved in the binding of arfaptin 2 to small GTPases are not conserved in ICA69 (Fig.  8A) , suggesting that ICA69 may interact with small GTPases other than ARF1 or Rac1. DISCUSSION We have shown here that ICA69 is peripherally associated with the Golgi complex and ISGs. This conclusion is consistent with results obtained by confocal microscopy, immunoelectron microscopy, and subcellular fractionation. Additional support for these findings has been obtained using pharmacological treatments that affect the organization of the Golgi complex and post-Golgi membrane compartments.
Previous studies suggested that the C. elegans homologue of ICA69, termed ric-19, is associated with neuronal SVs (3). A deletion mutant of ric-19, in particular, was shown to confer resistance to the acetylcholinesterase inhibitor aldicarb, thus implying a reduced secretion of acetylcholine from SVs at neuromuscular junctions. Confocal microscopy on brain sections, however, did not reveal a co-localization of ICA69 with SV markers. In INS-1 cells ICA69 also did not co-distribute with markers of SLMVs, the counterpart of neuronal SVs in peptidesecreting endocrine cells (64) . Furthermore, ICA69 was not found on purified brain SVs nor co-distributed with SLMVs upon fractionation of INS-1 cells. Thus, our data do not support the notion that ICA69 is enriched on SVs/SLMVs. This conclusion, however, is not in conflict with the observation that mutation of ric-19 hinders the secretion of acetylcholine. Impaired secretion may result from alterations in membrane trafficking upstream of SVs/SLMVs.
Our findings point to a tight connection of ICA69 with the trans-face of the Golgi complex, from which SGs and precursors of SVs/SLMVs originate. Immunoelectron microscopy showed the presence of ICA69 on SGs in the process of budding from the TGN. Upon microtubule disruption (nocodazole treatment), microtubule reorganization (nocodazole, taxol treatment), Golgi-endoplasmic reticulum fusion and TGN-endosome fusion (BFA treatment), a pool of ICA69 remained associated with membranes positive for TGN38. Upon treatment with BFA, ICA69 also co-localized extensively with syntaxin 6 near the MTOC. Syntaxin 6 is a soluble N-ethylmaleimide-sensitive attachment protein receptor protein of the TGN and early endosomes (65) that was shown to redistribute around the MTOC in BFA-treated cells (66) .
Besides being enriched at the TGN, a minor pool of ICA69 is found on ISGs, whereas it is virtually absent from MSGs. Occasionally, ICA69 was detected on what appeared to be small vesicles pinching off the membrane of SGs. Whereas the presence of a coat was not readily apparent, such profiles could conceivably represent budding clathrin-coated vesicles that remove proteins not destined to MSGs (57, 67, 68) . Protein removal from ISGs is part of the maturation process that leads to the formation of MSGs (69, 70) . The departure of ICA69 from ISGs together with these vesicles could explain its absence on MSGs. In this respect, ICA69 resembles again syntaxin 6, A, arrows) . B, upon mild destabilization of the microtubule cytoskeleton by nocodazole/taxol treatment, ICA69 immunoreactivity (pseudored) overlapped with TGN38 (pseudogreen) in a bipolar manner at opposite sides of the nucleus, near the centrioles, as visualized with anti-␥-tubulin antibody (pseudogreen) (C). D, BFA treatment reduced ICA69 immunoreactivity, whereas the integral membrane protein TGN38 redistributed to the endoplasmic reticulum. E, the residual ICA69 immunoreactivity was concentrated in one or two bright clusters close to the MTOC (not shown), which did not overlap with GM130-positive structures (pseudogreen) (E). A large fraction of ICA69 co-localized instead with syntaxin 6 (pseudogreen) (F).
which is also associated with ISGs but not with MSG of ␤-cells (11, 57) . Additional studies will be necessary to determine whether ICA69 plays an active role in the maturation process of ISGs.
The similarity of ICA69 with arfaptins strongly suggests that ICA69 participates in membrane trafficking. Arfaptin 1 binds to ARF proteins in their GTP-bound conformation (8) . ARFs, in turn, regulate membrane dynamics by promoting the recruitment of coat proteins on membranes as well as by affecting the activity of phospholipid-modifying enzymes and the organization of the actin cytoskeleton (71, 73) . In addition to ARFs, arfaptin 2 can also bind Rac and has therefore been proposed as a potential mediator of cross-talk between ARF and Rac (7, 63, 74) . Given the sequence similarity of the Nterminal region of ICA69 with the arfaptin Dbl homology-like domain, it is conceivable that ICA69 dimers might also bind small GTPases. Additional studies will be required to identify its binding partners. Thus, our findings raise the possibility that ICA69 acts in concert with small GTPases in regulating membrane dynamics at the Golgi complex and ISGs. The wide tissue expression of ICA69 (1, 4, 5) , suggests that this regulation may not be restricted to neuroendocrine cells.
Evidence that ICA69 is found on the TGN and ISGs of INS-1 cells provides additional support to the notion that in type 1 diabetes autoantibodies are preferentially directed toward proteins associated with the post-Golgi secretory machinery of ␤-cells (75) . Interestingly, ICA69 has also been recently identified as an autoantigen in Sjögren's syndrome (6) , an autoimmune disorder that affects primarily the exocrine cells of the salivary gland. Autoantibodies of patients with Sjogren's syndrome are typically directed against proteins associated with the Golgi complex (76) . The association of ICA69 with Golgi membranes and insulin-containing secretory granules could therefore account for the occurrence of ICA69 autoimmunity in both Sjogren's syndrome and type 1 diabetes. Future studies will determine the contribution of ICA69 to membrane traffick- ing and the significance of autoimmunity against ICA69 in diseases affecting secretory cells.
